Cardiology

welcome message

Welcome to the esteemed 3rd International Conference on Cardiology, a pivotal gathering poised to illuminate the latest advancements in cardiovascular research and practice. Set against the backdrop of London, UK, on October 17-18, 2024, World Cardiology 2024 promises to be a nexus of innovation, collaboration, and expertise.

Distinguished delegates, esteemed speakers, and esteemed guests, your presence fuels the momentum of progress in the realm of cardiology. Together, let us delve into cutting-edge discoveries, engage in insightful discussions, and forge enduring connections that will shape the future of cardiovascular health.

As we convene in this vibrant metropolis, let us harness our collective knowledge and passion to confront the challenges ahead, driving towards a world where heart health knows no bounds. Welcome to World Cardiology 2024, where the heartbeat of innovation resonates, and the pulse of progress beats strong.

 

About Conference

The 3rd International Conference on Cardiology is a premier event dedicated to advancing the field of cardiovascular medicine and science. Held in the dynamic city of London, UK, on October 17-18, 2024, this conference is a cornerstone of the World Cardiology 2024 series.

At this ground breaking gathering, leading cardiologists, researchers, clinicians, and industry professionals from around the globe converge to share insights, exchange knowledge, and collaborate on the latest developments in cardiology. From ground breaking research presentations to interactive workshops and panel discussions, the conference offers a multifaceted platform for exploring the most pressing issues facing cardiovascular health today.

With a diverse array of topics spanning from preventive cardiology to innovative treatment modalities and emerging technologies, attendees can expect to gain valuable insights into the forefront of cardiovascular science and clinical practice. Moreover, the conference provides unparalleled networking opportunities, fostering connections and partnerships that drive advancements in patient care and outcomes.

World Cardiology 2024 promises to be a transformative experience, uniting the brightest minds in cardiology to collectively tackle the challenges and opportunities that lie ahead. Join us in London as we embark on a journey towards a healthier, more resilient future for heart health worldwide.

Conference highlights include:

• 100+ participants (Both Industry and academia)
• 11+Keynote speakers
• 30+ Plenary speakers
• 10+ Exhibitors
• Innovative educational sessions
• B2B meetings
• Hands-on Workshop

Why to attend conference:

1. Cutting-Edge Insights: Gain access to the latest research findings, advancements, and breakthroughs in the field of cardiology. Stay ahead of the curve by learning from leading experts and innovators.

2. Networking Opportunities: Connect with a diverse community of cardiologists, researchers, clinicians, and industry professionals from around the world. Forge valuable collaborations, exchange ideas, and expand your professional network.

3. Professional Development: Enhance your knowledge and skills through engaging workshops, interactive sessions, and hands-on demonstrations. Acquire practical tools and strategies to improve patient care and outcomes in your practice.

4. Multidisciplinary Approach: Explore cardiology from various perspectives, including preventive cardiology, interventional cardiology, electrophysiology, imaging, and more. Gain insights from experts across different specialties and disciplines.

5. Stay Updated: Stay abreast of the latest guidelines, protocols, and best practices in cardiovascular medicine. Learn how to integrate evidence-based strategies into your clinical practice to optimize patient care.

Target Audience:

• Cardiologists
• Scientists
• Physicians/Consultants/ General Practitioners
• Directors/Managers
• Pathologists/ Nurses
• Presidents & Vice Presidents/ Directors / Administrators
• Business Entrepreneurs
• Cardiology Associations/ Societies
• Training Institutes
• Young Researchers
• Medical Students
• Residents
• Medical Devices Companies
• Acadamic Scientists
• Research Scholars
• Business Delegates
• Sonographers
• Pharmacologists

Sessions & Tracks

Track 01: Clinical Cardiology

Clinical cardiology focuses on the diagnosis and management of cardiovascular diseases in adults. It involves evaluating patients' symptoms, performing diagnostic tests (such as ECG, echocardiography, and stress tests), and implementing treatment plans tailored to each individual's condition. management guidelines for common cardiovascular conditions (such as coronary artery disease, heart failure, valvular heart disease), lifestyle interventions, patient education, and shared decision-making.

Track 02: Pediatric cardiology

Experts in diagnosing and treating cardiac problems in children are paediatric cardiologists. For kids who could need heart surgery, paediatric cardiologists and paediatric cardiac surgeons work closely together to determine the best course of action. A range of heart problems can affect children. Certain structural differences are inherited. Some are related to the electrical circuitry that controls pulse frequency.

Track 03: Pediatric heart transplant

Heart transplantation for infants and children is becoming a more common kind of treatment. According to the International Society for Heart and Lung Transplantation registry, between 600 and 700 child heart transplant procedures are performed annually globally, making up around 12% of all heart transplants. In older children, cardiomyopathy is the most common reason for heart transplantation. An increasing proportion of children with congenital heart disease receive palliative surgery, only to have their cardiac function deteriorate over time. 

Track 04: Hypertension

The disorder known as high blood pressure affects the arteries in the body. Also referred to as hypertension. If your blood pressure is excessive, the blood's continuous force on the arterial walls is too great. The heart has to work harder to pump blood. Blood pressure is measured in millimetres of mercury, or mm Hg. High blood pressure is often defined as a measurement of 130/80 mm Hg or higher.

Track 05: Cardiovascular diseases

Conditions affecting the heart or blood vessels are collectively referred to as "cardiovascular disease" (CVD). Atherosclerosis and the buildup of fatty deposits inside arteries, which cause them to stiffen and narrow (thrombosis), can result in reduced blood flow to the body, brain, or heart. Children and teenagers are susceptible to certain types of heart disease called cardiovascular disorders. Rheumatic cardiac diseases are thought to be brought on by an autoimmune response.

Track 06: Nuclear Cardiology

Nuclear cardiology studies use noninvasive techniques to detect myocardial blood flow, evaluate the heart's pumping capacity, and pinpoint the site and severity of a heart attack. The most often used nuclear cardiology technique is cardiac perfusion imaging. To evaluate blood flow to the heart muscle, myocardial perfusion images are combined with exercise. There are two ways to exercise: using a stationary bike or a treadmil.

Track 07: Cardiology and Covid 19

Early reports from Wuhan, China on the epidemiology of COVID-19 warned of serious complications that would likely occur in elderly patients and those with pre-existing cardiovascular disease, including acute respiratory distress syndrome, cardiogenic shock, thromboembolic events, and death. Consequently, several reports from all around the world, including US and European investigations, have confirmed similar conclusions.

Track 08: Cardiac Pharmacology

The field of cardiovascular pharmacology includes the classes of medications used to treat and manage cardiovascular diseases include hypertension, heart failure, angina, and arrhythmias. One of the most significant public health issues and a significant financial burden on Western healthcare systems is cardiovascular disease. The functionality and quality of life of those who are impacted by them might be seriously compromised by their associated morbidity.

Track 09: Prenatal Cardiology

Because the foetus does not use its own lungs until delivery, its circulatory system is different from that of a new born baby. The growing infant inside the uterus (womb) of the mother is referred to as a foetus. The placenta is a special organ that provides all of the nourishment a developing baby needs. One side of the placenta is attached to the uterus, and the other side is attached to the sac filled with liquid that contains the foetus. The umbilical cord is a special chord that connects the placenta and the growing foetus.

Track 10: Cardiac Electrophysiology

An electrophysiology (EP) inquiry, also referred to as an invasive cardiac electrophysiology study, is a series of tests that examine the electrical activity of the heart. The heart's electrical activity produces impulses, or signals, that control how frequently the heart beats. During an EP study, cardiologists can create an extremely accurate map of the signals that go between each heartbeat.

Track 11: Women’s Cardiology

The internal appearance of a healthy heart is nearly identical. For women, this means that your heart health is unique. Women are particularly vulnerable to a range of heart-related issues because of the minute anatomical differences in their hearts. Heart disease is the top cause of death for women in the United States. It's important to be aware of your risk factors and to see a doctor if you feel concerned.

Track 12: Cardiomyopathy and Stroke

Hypertrophic cardiomyopathy (HCM) is most likely to develop in patients with ischemic stroke (IS), mortality, cardiovascular death, all strokes, and major cardiovascular events, such as ventricular arrhythmias leading to cardiac arrest and rehospitalization for heart failure.
• Risk stratification needs to be enhanced, particularly by utilising user-friendly techniques, in order to assist in identifying those HCM at higher risk of IS.
• Using a complex weighted score that considers variables like age, the presence of AF, the age at which AF first manifested, prior thromboembolism, New York Heart Association class, left atrial size, mean wall thickness, and vascular disease, the HCM Risk-CVA (cerebrovascular accident) score can be used to predict IS.

Track 13: Cardiovascular Imaging and Image Analysis

Using medical images, cardiovascular imaging is a diagnostic radiography technique used to diagnose circulatory problems and identify anomalies in the heart. Numerous diseases can be identified with it, such as: • Cardiovascular disease.
• Heart failure or valve problems.
• A cardiac attack resulting in damage.
• Hereditary heart disorders
• Thyroid disease; • Heart tumours.
 

Track 14: Heart Transplantation

During a heart transplant process, a healthy donor heart is used to replace a failing heart. Those whose symptoms have not improved enough with medication or other surgeries are usually in need of a heart transplant. Even though a heart transplant is a major operation, with the correct aftercare, your chances of survival are high.

• Cardiomyopathy, or weakening of the heart muscle;
• Cardiovascular disease
• Heart valve problems

Track 15: Pregnancy-related heart conditions

There may be challenges unique to cardiovascular illness during pregnancy. Increased blood volume and heart rate, in addition to other pregnancy-related changes, can put extra strain on the heart, aggravating pre-existing conditions and causing new cardiovascular issues. We provide highly skilled treatment for women with cardiovascular illness before, during, and after pregnancy as part of Brigham and Women's Hospital's (BWH) Cardiovascular Illness and Pregnancy programme.

Track 16: Cardiovascular Imaging Advance

Recent developments in cardiovascular imaging methods and technology are examined in this topic. Artificial intelligence applications for image analysis, contrast-enhanced imaging, 3D reconstruction, and high-resolution imaging are among the innovations. In cardiology, these developments improve diagnostic precision and enable individualised therapy planning.

Track 17: Heart failure management

The goal of heart failure management is to enhance the prognosis, quality of life, and symptoms of those who suffer from this illness. It includes a range of tactics, such as dietary changes, prescription drugs, and even surgical procedures.

• ACE inhibitors and diuretics
• BETA-blockers
   

Track 18: Innovations in Cardiac Surgery

Innovations in cardiac surgery have led to the development of minimally invasive procedures, which involve smaller incisions and less tissue damage compared to traditional open-heart surgery. These techniques can result in faster recovery times, reduced pain, and lower risk of complications for patients.

• Robotic-Assisted Surgery
• Tissue Engineering and Regenerative Medicine
• Hybrid Procedures

Benefits of Participation

• The advantages of the speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
• Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our conference.
• Meet with hundreds of like-minded experts who are pioneers in COPD 2023 and share ideas.
• All participants in the conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
• A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of cardiology at our Keynote sessions.
• COPD 2023 intensive Conference schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognized professionals.
• Best Poster Award nominations.
• Award for Outstanding young researcher
• Group Registration Advantages.

Benefits of Participation for Speaker

• Access to all Sessions (Keynote, Plenary, Poster, E-Poster)
• Certificate Accreditation from the Organizing Committee
• Abstracts will be published in the conference souvenir and respective international journal
• Each registrant will get 50% abatement on manuscript publication fees
• Access to the attendees email list (post conference)
• Worldwide appreciation of the profile of research
• Obtain credits for professional growth.
• Explore the latest of cutting edge analysis.
• Make long-term bonds at social and networking activities.
• An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
• Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of cardiology
• We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

• Professional Development-Improve understanding and knowledge
• Attendance at conferences supports rejuvenates and energizes delegates.
• Your involvement in our conference will help with a new methodology and ideology that can be used to broaden the outcomes of business or industries.
• Opportunities for World Cardiology 2024 researchers and experts in the same field to meet and exchange new ideas through a Cardiology Conference.  

Benefits of Participation for Sponsor

• Exposure to the international environment would increase the possibility of new companies
• Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
• Increase business by our conference participants through lead generation.
• It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
• Conferences in cardiology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
• Benchmarking main organisation  plans